Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID VA644A91218· VHA· 644-PHOENIX· 3650 · CHEMICAL & PHARMACEUTICAL MACHINE· FY2009· $68,631 net obligations· UEI DKCXLGANZAN3· CT

Description

SOLIRIS (ECULIZUMAB) 300MG

First action · last action
2009-07-07 · 2009-07-07
Transactions
1
First transaction's obligation
$68,631
Base + all options value (sum of deltas)
$68,631
Extent competed
NON-COMPETITIVE DELIVERY ORDER
Other than full & open authority
FOLLOW-ON CONTRACT
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5942X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$68,631$0Base award · 2009-07-07 · this action $68,631 · running total $68,631
  • Base2009-07-07+$68,631= $68,631
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2009-07-07+$68,631$68,631SOLIRIS (ECULIZUMAB) 300MG

Related awards · 7

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 3650 from 644-PHOENIX (most recent first)

AwardRecipientOfficeNet obligationsFY
VA644A91217SEQIRUS USA INC644-PHOENIX$40,375FY2009

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA644A91218_3600_V797P5942X_3600 · retrieved 2026-09-26.